HLA-C and infection: Furthermore, the stability of the HLA-C-β-2 microglobulin (β2m)-peptide complex determines antigen presentation efficiency, with less stable variants linked to impaired immune responses, increased infection risk, and reduced immunotherapy efficacy (7–9).